Sunday, March 27, 2011

Imidazole-Containing Peptidomimetic NACA as a Potent Drug for the Medicinal Treatment of Age-Related Cataract in Humans

Summary: N-alpha-acetylcarnosine probably does good things for cataract patients

Interestingness: 2

Paper by Mark A Babizhayev, Valentina N Yermakova, Anatoly I Deyev and Marie-Christine Seguin. in the Journal of Anti-Aging Medicine, Volume 3, Issue 1, Spring 2000.

(((
Smallish trial on 49 humans, seeing if N-alpha-acetylcarnosine (NACA) does something for the eyes of cataract patients that are not in bad enough conditiones to go to surgery for it. It seems to do things, good things.

The theory is that the NACA gets converted to L-carnosine in vivo, and this acts as an anti-oxidant preventing or reversing cataracts. Not much more is given, but inhibition of phosphatidylcholine liposomal peroxidation is mentioned. Phosphatidylcholine is a major component of the cell membrane.

They give the NACA in drops to the eyes for two years. All the improvement is seen in the first six months, and after that the levels are maintained. Control subjects deteriorate quite a lot in the period.

This paper has a very long methodology section that probably means something to ophtamologists and optometrists. It also has a lot of decent graphs in the results section.
)))


The objective of this manuscript is to test the efficacy of Nalpha-acetylcarnosine for the treatment of senile cataract in humans. It was designed as a randomized controlled trial. Forty-nine subjects-volunteers (76 eyes) with an average age of 65.3 ± 7.0 years were enrolled and randomized into two groups at diagnosis of senile cataract. Changes in lens clarity were measured and quantitated over 6 to 24 months thereafter. Patients administered 1% Nalpha-acetylcarnosine (NACA) (26 patients, 41 eyes = Group II), placebo composition (13 patients, 21 eyes) topically (two drops, twice daily) to the conjunctival sac, or were untreated (10 patients, 14 eyes); two latter groups of patients were combined into the control (reference) group I. Patients were evaluated upon entry, at every 2-month (Trial 1) and 6-month (Trial 2) intervals for best corrected visual acuity (b/c VA), by ophthalmoscopy, original techniques of glare test (Trial 1), stereocinematographic slit-image and retro-illumination photography with subsequent interactive digital image analysis and 3D computer graphics of the lens light scattering/absorbing centers. The intra-reader reproducibility of measuring techniques for cataractous changes was good with the overall average of correlation coefficients for image analytical data 0.830 and glare test readings 0.998. Group I of patients demonstrated the variability in densitometric readings of lens cloudings, negative advance in glare sensitivity over 6 months, and gradual deterioration of VA and gross transmissivity of lenses over 24 months comparatively to baseline and the 6-month follow-up examinations. As compared with baseline examination, over 6 months 41.5% of the eyes treated with NACA presented a significant improvement of the gross transmissivity degree of lenses, 90.0% of the eyes showed a gradual improvement in VA to 7-100% and 88.9% of the eyes ranged a 27-100% improvement in glare sensitivity. Topographic study demonstrated less density and corresponding areas of opacification in posterior subcapsular and cortical morphological regions of the lens consistent with VA up to 0.3. The total study period over 24 months revealed that the beneficial effect of NACA is sustainable. No cases resulted in a worsening of VA and image analytical readings of lenses in the NACA-treated group of patients. In most of the patients drug tolerance was good. Statistical analysis revealed the significant differences over 6 and 24 months in cumulative positive changes of overall characteristics of cataracts in the NACA-treated group II from the control group I. The N-acetylated imidazole-containing peptidomimetic NACA is proposed as an effective and physiologically acceptable drug for nonsurgical treatment of age-related and senile cataracts.

Tuesday, March 22, 2011

Neutrophil Phagocytic Function and Humoral Immune Response with Reference to Ascorbate Supplementation in Aging Humans

Summary: Vitamin C supplementations makes some immune system numbers in old people resemble the ones in young people

Interestingness: 3

Paper by Muthuvel Jayachandran, Packiasamy Juliet Arockia Rani, Palaniyappan Arivazhagan and Chinnakkannu Panneerselvam in the Journal of Anti-Aging Medicine, Volume 3, Issue 1, Spring 2000.

(((
The methodology description is a little bit confusing, but I think they grabbed 125 20-to-30 year olds and 132 >60 year olds, measured some immune system function numbers: neutrophil phagocytic index (guessing, how easily they eat things), neutrophil avidity index (guessing again, some kind of bonding strength measurement), nitroblue tetrazolium (NBT) reduction (some kind of neutrophil phagocytic potency measurement it says), leucocyte ascorbic acid (how much ascorbic acid in the white blood cells, supposedly a good thing), immunoglobin G, M and A, complement C3 (some protein complex that punches holes in bacteria) and soluble immune complex (SIC) index (nfi).

Old people's numbers were 0.001-significantly lower for the avidity index, the NBT reduction, the leucocyte ascorbic acid, the IgG, IgM, the C3 and SIC index. Taking vitamin C for 30, 60, or 90 days didn't change the youngun's numbers, but the oldies got all those numbers within the non-0.001-significant level off the young, mostly within one standard deviation, and crossed the 0.001 level from their previous measurement.

Sounds good. Reasons not to get excited: we know vitamin C does nothing good for lifespan in humans.

)))


Abstract follows:

Age-associated deficiency of vitamin C contributes to the impaired humoral immune response, which in turn plays a role in the increased risk of illness in old age. Healthy volunteers were given vitamin C supplementation. Neutrophil phagocytic function, complement C3 concentration, and immunoglobulin status were measured at 30, 60, and 90 days. Neutrophil phagocytic function and levels of serum IgG and IgM and leukocytic ascorbate were considerably lower in the aged humans, but these decreases were attenuated by vitamin C supplementation. The level of IgA was not affected by aging. Improved neutrophil phagocytic function and humoral immune response were associated with increased vitamin C status in the aged population and might well contribute to the decreased risk of disease in the aged.

Wednesday, March 16, 2011

Noncorrelation Between Maximum Life Span and Antioxidant Enzyme Levels Among Homeotherms: Implications for Retarding Human Aging

Summary: de Grey thinks that we need superoxide dismutase in our mitochondrial intermembrane spaces

Interestingness: 6

Paper by Aubrey DNJ de Grey in the Journal of Anti-Aging Medicine, Volume 3, Issue 1, Spring 2000.

(((

This is another theory/speculation paper by de Grey. He's trying to explain why there is no correlation between life span and antioxydant enzyme levels in warm blooded animals. His explanation sticks to the oxidative damage is bad, m'kay, trend and tries to fit the model to the data.

He partitions the rate of damage created by oxidation into four:
  • Specific metabolic rate (SMR): rate of consumption of oxygen per gram of body.
  • Leakiness: Proportion of oxygen that becomes superoxide.
  • Superoxide potency (SP): Proportion of superoxide converted into other oxide radicals (eg hydrogen peroxide) instead of being pacified by antioxidant enzymes.
  • Oxidisability of the tissue (OT): How easily the relevant tissue gets oxidised.

He notes that under this scheme, levels of antioxidant vitamins affect the OT and not the SP, since they act mainly to stop the chain of oxidation. SP is the rate factor that is not correlated with lifespan that is being explained in this paper.

SMR in warm blooded animals (homeotherms) is mostly determined by body size, and lifespan does correlate with body size. Lifespan depends not only on size though but seems to be well correlated with lifespan restrictions imposed by external causes. There isn't much evolutionary pressure to raise the aging-based lifespan of the animal if it is likely to die from other causes (eg getting eaten). Animals of similar weight but different chances of dying due to external causes have different lifespans (eg birds vs mammals).

In a study in primates, superoxide dismutase (SOD) did correlate with lifespan if the SOD levels were divided by the SMR when doing the calculation. Catalase, glutathione peroxidase (GP) and glutathione (G) didn't though. A less dodgy comparison, in that it didn't need the division by SMR factor, was one between rats and pigeons. Pigeons live about 8 times longer than rats even though they weight about the same. SOD levels in the pigeon were slightly higher, catalase much lower, and G and GP levels varied depending on the tissue. Another study showed similar results when looking at the canary (very low mass, very high lifespan), with not even SOD showing higher levels.

In the same studies, they showed a correlation between leakiness and rate of aging, and maybe one between OT and rate of aging. Lending support to this second correlation, de Grey mentions that fatty acids saturation in the membranes of the mitochondria and levels of non-enzymatic anti-oxidants (eg vitamins C and E) are higher in longer lived animals and these lower OT. This supposedly leaves SP as the only one out of the four factors that doesn't correlate in the predicted way with longevity.

de Grey's hypothesis to explain this is that there is no easy way for evolution to lower the SP because there are no SOD enzymes in the mitochondrial intermembrane space (MIMS) to mop up the superoxides. The selection for longer lifespan instead pushes the concentrations of non-enzymatic antioxidants (vitamins C and E) up all over the cell to get levels up in the MIMS, and the leakiness of the MIMS down which is the same mechanism that controls leakiness elsewhere in the chain. This then means that the concentrations of antioxidant enzymes in the non-MIMS regions become too high for the resulting lower radicals due to the improved leakiness and non-enzymatic antioxidant profiles, and these enzymatic antioxidant levels drift down to save resources until they match the levels that would lead to the same rate of damage as the other parts of the oxidation chain.

Since that paragraph contained the whole hypothesis I will write it again, but in expanded form. Homeotherms supposedly don't have any SODs in their MIMS but we do produce superoxides there (the evidence for that second part is probably not great). The damage caused by this, somehow (more on this later), limits our lifespan. For intelligent or otherwise flighty animals, where the external causes of dying are lower, there is a selective pressure, apparently, to raise our lifespan due to aging to match the lower external causes. Since it seems to be troublesome to introduce a SOD into our MIMS (and this supposed trouble to evolve a MIMS-SOD is the bit that to me seems weakest out of the chain of reasoning), homeotherms instead reduce the leakiness of the ATP-making mechanism, the leakiness factor, and raise the levels of non-enzymatic anti-oxidants, lowering the OT factor, to lower the total rate of aging. Now, lowering the leakiness of the process lowered the production of oxidants everywhere, not just in the MIMS, and raising the level of non-enzymatic anti-oxidants did the same everywhere, not just in the MIMS, so now, if we kept the same level of enzymatic anti-oxidants as before these last two improvements, the level of oxidants everywhere non-MIMS becomes too low for the available enzymatic anti-oxidants. By too low, he means that the bottleneck will be the MIMS oxidants, and everywhere else the oxidant damage will always be too low to matter. Since now the organism can get away with lowering the enzymatic oxidant levels in the non-MIMS sections, it does so, since it saves energy doing so.

That this non-correlation between enzymatic antioxidant levels and lifespan does not occur in flies and worms, (ie, in those species, the correlation does exist and is positive), means that the lifespan-limiting mechanism in flies and worms is different from homeotherms. de Grey suggests that this mechanism is the mutation of mitochondrial DNA (mtDNA) which tends to be attached to the inner surface of the inner membrane of the mitochondria. The mtDNA would somehow be damaged by the higher unquenched superoxide concentration across the inner membrane, in the MIMS. Old mammals have been shown to have high levels of mtDNA mutations, while this doesn't happen in flies and worms, maybe because they do not live long enough for the process of mtDNA amplification to take place. He's trying to tie it all back to his other paper (http://readingrejuvenationresearch.blogspot.com/2010/01/proposed-refinement-of-mitochondrial.html)

The suggested methods for testing the hypothesis: retarget MnSOD and CuZnSOD to the MIMS and check that they are useless there. If they are not useless, then it should have been easy to evolve those. Afterwards, retarget E Coli's iron-dependent SOD to the MIMS of mice, as has supposedly been done before in yeast, and see if that affects lifespan. That last check doesn't make sense to me. If the enzymatic anti-oxidants in the non-MIMS sections have drifted down until they are causing as much trouble as the MIMS oxidation, then lowering MIMS oxidation damage shouldn't affect the lifespan of the beasts. Doing this while raising enzymatic anti-oxidants throughout the cell might though.

In conclusion, another very interesting chain of causation hypothesis, but probably too long to have much of a chance of being correct.

)))


Abstract follows:

A series of studies over many years has conclusively disproved the hypothesis that longevity in warm-blooded animals (homeotherms) correlates with high levels of antioxidant enzymes: in fact, these variables generally exhibit a strong negative cross-species correlation. In flies and nematodes, however, substantial extension of maximum life span has resulted from genetic manipulations that increase antioxidant enzyme levels; these manipulations have always been associated with increased resistance to oxidative challenge, indicating that the life span extension is directly caused by the raised antioxidant capacity. This stark contrast merits careful analysis because it casts doubt on the value of short-lived invertebrates as models for the investigation of mammalian aging. Here is it shown that these results imply the existence, in homeotherms but not in flies or worms, of life span-limiting pathways of oxidative damage that are impervious to enzymatic antioxidants. This is shown to lend weight to the currently controversial theory that somatic mitochondrial DNA mutations contribute significantly to determining the rate of aging of homeotherms, and thereby suggests a feasible intervention to retard human aging.

Saturday, February 19, 2011

Prevalence of Telomerase in Coronary Artery Atherosclerosis

Summary: Telomerase detected in atherosclerotic plaque tissue, likely to be related to restenosis.

Interestingness: 3

Paper by Madhu Gupta, Marie R Shogreen, Gregory A Braden, Wain L White and David C Sane in the Journal of Anti-Aging Medicine, Volume 3, Issue 1, Spring 2000.


(((
They measured the presence of telomerase in the bits cut out of 23 people that had directional coronary atherectomy (DCA). The bits cut out are blockages of the coronary artery and the DCA cuts it out. They correlated the tissues in which they detected telomerase with those that had restenosis, which is when the blockage/narrowing of the artery reappears.

They detected telomerase in 8 out of the 23 total, in 5 out of the 7 people who later developed restenosis, and on 2 out of the 10 who didn't (p < 0.05). Results were inconclusive for restenosis in the other 6. There was no correlation between what the people had come in for and the presence of telomerase.

They mention that atherosclerotic plaques have a monoclonal population of smooth muscle cells, but I don't know what other type you could have inside one person. They offer three explanations for the 35% detection rate of telomerase, that is, how come it's not 100%:

  • that the tissue is maintaining its telomeres by means other than telomeres
  • that the tissue is senescent or closer to senescence, with some evidence coming from studies on replicative capacity of muscle cells from plaque-derived tissue compared to healthy arteries. The presence of telomerase would probably be induced by cells having replicated beyond the normal senescent stage by a viral infection or broken tumor-suppressors, and that this would activate telomerase. These cells would then be better able to cause restenosis. I have no idea how much reality there is to that idea of telomerase reactivation.
  • that there was no telomerase in the smooth-muscle cells at all, and instead the telomerase was detected from other cells in the tissue cut out. This could be from vascular stem cells, or from non-related cells like endothelial cells, lymphocytes or macrophages.

They also mention that the telomerase could be driving the hyperplasia not by replication but by stopping apoptosis.

)))


Abstract follows:

Telomerase is an essential enzyme for maintaining the telomeres of chromosomes and thereby enhancing the sustained replication of cells. Because atherosclerosis and restenosis are characterized by cellular proliferation, we determined whether telomerase enzyme activity was present in coronary artery tissue from 23 patients undergoing directional coronary atherectomy. Telomerase activity was determined from detergent lysates of the atherectomy tissue using an enzyme-linked immunoadsorbent assay (ELISA)-based modification of the Telomere Repeat Amplification Protocol. The presence of telomerase activity was correlated with the occurrence of coronary artery restenosis. Eight of the 23 samples (35%) were positive for telomerase. Seventeen of the 23 patients had adequate clinical follow-up to judge restenosis status. Of these, 7 had restenosis and 5 of these 7 had detectable telomerase. Of the 10 patients without restenosis, 8 were telomerase negative (p <= 0.05). We have shown, for the first time, that telomerase is found in 35% of atherosclerotic tissues. There was a strong trend toward an association between telomerase presence and restenosis in patients for whom follow-up data were available. The presence of telomerase in atherosclerotic tissue may enable a robust, sustained cellular proliferation in response to vascular injury that culminates in restenosis.

Sunday, February 6, 2011

Rest of volume 2, Issue 4

The rest of issue 4 of 1999 consists of:

A review of a book called Essentials of Clinical Geriatrics, 4th edition, edited by Robert L Kane, Joseph G Ouslander and
Itamar B Abrass. "Concise" 621 pages of differences between geriatric and standard medicine.


Seven article reviews by L Stephen Coles:
  • Gene expression profile of aging and its retardation by caloric restriction, by Cheoi-Koo Lee, Roger G Klopp, Richard Weindruch and Tomas A Prolla, in Science. Analysis of what genes change in muscle cells in old mice compared to young mice compared to old calorie restricted mice using a gene chip of 6000 genes. Lots of changes, with caloric restriction reducing the changes by 84%. L Stephen Coles thought this was a very important paper.
  • Can human aging be postponed?, by Michael R Rose, in Scientific American. Some pop-sci sounding piece.
  • Designer genomes, by Karen Hopkin, in Scientific American. Another pop-sci sounding piece about creating cells from scratch. Mentions Venter's knock out method of finding the minimal set. I didn't know he had been going at it that long.
  • Telomeres and telomerase in cancer, by Christopher M Counter, in Science and Medicine. Supposedly nice graphics.
  • Aging: The price of evolutionary success, by Robert F Rosenberger, in Science Spectra: The international magazine of contemporary scientific thought. About germ vs soma.
  • The hunt for the youth pill: From cell-immortalizing drugs to cloned organs, biotech finds new ways to fight against time's toll, by David Stipp, in Fortune Magazine.
  • Never say die, by Lisa Leff, in the Los Angeles Magazine.

Season of Birth and Human Longevity

Summary: Adult women over thirty live three years longer if they were born in May or December, rather than in August.

Interestingness: 2

Paper by Leonid A Gavrilov and Natalia S Gavrilova in the Journal of Anti-Aging Medicine, Volume 2, Issue 4, Winter 1999.

(((
Short two-page paper analysing a subset of the same data they used for their longevity vs fertility paper, ie European aristocratic families. In this case, they analysed a lot of variables until they found one that correlated with longevity.

On the relevant subsample of 4911 women, adult women over 30 born between 1800 and 1880 lived shortest if they were born in August and longest if they were born in May with the difference at about three and a half years. This is after correcting for a whole heap of variables that have nothing to do with month of birth but are related to longevity: year of birth, maternal and paternal life spans, age of parents at birth, birth order, nationality, whether the death was violent, loss of either or both parents before age twenty.

They have a graph and it doesn't look good to me. The only reasons I can think of, and that they propose, for the effect would be availability of vitamins (or calories but they are unlikely to be a problem for this group since they were all from aristocratic families) at specific points in the pregnancy or early life, but the graph is very noisy and it mostly jumps up and down. For example, the difference between July and August births is two and a bit years, and between August and September the difference is about a year and a half, with August at the minimum. The other bad months are February and March, on the other side of the year, with women born then living about a year longer than those in August. If the effect is real, then the critical periods during pregnancy must be very short.

I'm not buying any of it until it gets replicated.
)))

Adaptive Response to Swimming Exercise: Antioxidant Systems and Lipid Peroxidation

Summary: Anti-oxidant enzyme concentrations go up in the blood of rats that go swimming

Interestingness: 1

Paper by M Cesquini, MA Torsoni and SH Ogo in the Journal of Anti-Aging Medicine, Volume 2, Issue 4, Winter 1999.

(((
The abstract has everything covered. Note that these tests were on three groups of four rats each. Also, catalase was down on the endurance-trained group.
)))


Abstract follows:

Enzymatic and nonenzymatic antioxidants play an essential role in protecting tissues from oxidative damage during exercise. The present study investigated the levels of glutathione and antioxidant enzyme systems in the blood of unexercised and exercised (one bout of exhaustive swimming and adapted to swimming endurance training) rats. The hemoglobin concentration, hematocrit, and extent of oxidative injury to red blood cell (RBC) membranes were examined in the above groups of rats. The concentration of reduced glutathione (GSH) in the blood of exercised rats was about 30% higher than in the resting controls (0.40 Å [±] 0.12 GSH/Hb tetramer). Glutathione peroxidase (1.83 Å 0.24 X 102 IU/g Hb), glutathione reductase (1.73 Å 0.44 IU/g Hb), and Superoxide dismutase activities were significantly higher in both groups of exercised rats, whereas catalase activity (8.32 Å 1.04 X 104 IU/g Hb) was similar in the exercised and control animals. The hemoglobin concentration (11.8 g Hb/dL) and hematocrit (39.4%) increased with swimming exercise. Although lipid peroxidation is known to occur following physical exercise, the increased activity of the antioxidant enzymes and cell GSH levels in the present study were able to prevent lipid peroxidation of the RBC membrane. As a result, there was no significant variation in the plasma malondialdehyde levels among the three groups of rats. The redox capacity of the blood may have an important role in the organism in general since the redox status can be transferred across the RBC plasma membrane to other tissues. Exercise training is therefore beneficial to general health and protects cells against deleterious effects of reactive oxygen species produced during physical effort.